<DOC>
	<DOCNO>NCT01390922</DOCNO>
	<brief_summary>The objective post-marketing surveillance study collect safety , efficacy usage data botulinum injection subject upper low limb spasticity long-term use clinical practice identify factor affect safety efficacy .</brief_summary>
	<brief_title>Special Drug Use Investigation BotoxÂ® ( Botulinum ) Spasticity ( BOTOX Registered Trademark Allergan , Inc . )</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Subjects upper low limb spasticity Subjects must use botulinum injection first time</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>